[Degenerated mitral bioprosthesis and severe aortic valve stenosis in a high-risk patient: a two-step transcatheter valve implantation].
Recently, small case series have described successful off-label use of transcatheter aortic valve implantation (TAVI) in patients with degenerated bioprosthetic valves in mitral position. We here report the case of a 78-year-old female patient who underwent TAVI for severe aortic stenosis and transapical valve-in-valve implantation for degenerated mitral bioprosthesis. There was no evidence of intraprosthetic regurgitation and/or paraprosthetic leaks on control angiography and transesophageal echocardiography. The postoperative course was uneventful. Following accurate patient selection and evaluation by an experienced multidisciplinary team, the transcatheter approach for double valve implantation in aortic and mitral position may represent a viable treatment option for those high-risk patients who otherwise would be inoperable.